Solesta Injectable Gel
PMA P100014
Active
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP100014 | Date27 May 2011 | StatusActive |
Official records
- FDA PMA database P100014
From the FDA record
FDA PMA P100014
- Received by the FDA
- 9 Apr 2010
- FDA decision
- 27 May 2011
- FDA review time
- 413 days from receipt to decision
- Docket number
- 11M-0445
APPROVAL FOR THE SOLESTA. THIS DEVICE IS INDICATED FOR THE TREATMENT OF FECAL INCONTINENCE IN PATIENTS 18 YEARS AND OLDER WHO HAVE FAILED CONSERVATIVE THERAPY (E.G., DIET, FIBER THERAPY, ANTI-MOTILITY MEDICATIONS).
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic name
- AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE
- FDA applicant
- Palette Life Sciences
- PMA number
- FDA product code
- LNM
- Device class
- Class III
- Advisory committee
- Gastroenterology, Urology
- FDA decision
- APPR Approved
Overview
AI-generated summary, 18 Sep 2026
Solesta Injectable Gel is an agent, bulking, injectable for gastro-urology use. It is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy such as diet, fiber therapy, or anti-motility medications.
The device is supplied as an injectable gel and is intended for use under medical supervision. It is a single-use product, and its authorization is based on FDA PMA approval (P100014). No information on sterility, MRI safety, sizes, or storage is provided in the data.
Devices cleared under P100014
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Solesta Gel 1.0 mL Syringe | 011506 / Gel 1.0 mL Syringe | 00850004725016 | Total Volume 1 mL | On the market |
Similar devices
Other devices filed under FDA product code LNM (Agent, Bulking, Injectable For Gastro-Urology Use).
- Bulkamid Urethral Bulking System by Boston Scientific
- Durasphere Injectable Bulking Agent by Carbon Medical Technologies, Inc.
- Enteryx Procedure Kit by Boston Scientific
- Coaptite Injectable Implant by Merz North America, Inc.
- Macroplastique Implants MPQ-2.5 by Uroplasty, LLC
- Bard URYX Urethral Bulking Agent by C. R. Bard, Inc.
- Macroplastique Implants by Uroplasty, LLC
- Contigen Bard Collagen Implant by Allergan